In vitro susceptibilities of common pediatric pathogens to LY163892

S. Shelton, J. D. Nelson

Research output: Contribution to journalArticlepeer-review

26 Scopus citations


LY163892 is a carbacephem antibiotic for oral administration with an antibacterial spectrum similar to that of cefaclor and amoxicillin-clavulanic acid. It has greater stability than cefaclor and greater activity against β-lactamase-producing Haemophilus influenzae and Escherichia coli. LY163892 is less active than amoxicillin against streptococci and less active than amoxicillin-clavulanic acid against Branhamella catarrhalis but comparable against other pathogens.

Original languageEnglish (US)
Pages (from-to)268-270
Number of pages3
JournalAntimicrobial agents and chemotherapy
Issue number2
StatePublished - 1988

ASJC Scopus subject areas

  • Pharmacology
  • Pharmacology (medical)
  • Infectious Diseases


Dive into the research topics of 'In vitro susceptibilities of common pediatric pathogens to LY163892'. Together they form a unique fingerprint.

Cite this